{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:37:17Z","timestamp":1772707037106,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1997,6]]},"DOI":"10.1136\/ard.56.6.341","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T00:32:33Z","timestamp":1228523553000},"page":"341-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Dyslipidaemia and rheumatoid arthritis"],"prefix":"10.1016","volume":"56","author":[{"given":"R D","family":"SITUNAYAKE","sequence":"first","affiliation":[]},{"given":"G","family":"KITAS","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/ard.56.6.341_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.56.6.374","article-title":"Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis.","volume":"56","author":"Munro","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.6.341_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/ard.49.6.363","article-title":"Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.","volume":"49","author":"Reilly","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.6.341_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0049-0172(95)80031-X","article-title":"Mortality in rheumatoid arthritis.","volume":"25","author":"Myllykangas-Luosojarvi","year":"1995","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1136\/ard.56.6.341_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/ard.53.10.621","article-title":"The significance of vascular inflammation in rheumatoid arthritis.","volume":"53","author":"Bacon","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.6.341_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199108083250601","article-title":"A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.56.6.341_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/ard.52.9.677","article-title":"Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis.","volume":"52","author":"Winyard","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.6.341_bib7","first-page":"52","article-title":"Antioxidants and atherosclerosis: a molecular perspective.","volume":"3","author":"Offermann","year":"1994","journal-title":"Heart Disease and Stroke"},{"key":"10.1136\/ard.56.6.341_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard.50.2.81","article-title":"Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates.","volume":"50","author":"Situnayake","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.6.341_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0009-9120(88)80094-8","article-title":"Serum total, HDL, LDL cholesterol and triglyceride levels in patients with rheumatoid arthritis.","volume":"21","author":"Lakatos","year":"1988","journal-title":"Clin Biochem"},{"key":"10.1136\/ard.56.6.341_bib10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/archinte.1987.00370110040005","article-title":"Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity.","volume":"147","author":"Svenson","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.56.6.341_bib11","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/archinte.1987.00370110045006","article-title":"Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of antiinflammatory and disease-modifying drug treatment.","volume":"147","author":"Svenson","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.56.6.341_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.50.6.366","article-title":"Lipoprotein (a), lipids and lipoproteins in patients with rheumatoid arthritis.","volume":"50","author":"Rantapaa-Dahlqvist","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.6.341_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0049-0172(92)90017-8","article-title":"Dyslipoproteinemia in the course of active rheumatoid arthritis.","volume":"22","author":"Lazarevic","year":"1992","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1136\/ard.56.6.341_bib14","first-page":"529","article-title":"Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis.","volume":"88","author":"Lip","year":"1995","journal-title":"Q J Med"},{"key":"10.1136\/ard.56.6.341_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/00365519509104968","article-title":"Lipoprotein (a) in relation to the acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica.","volume":"55","author":"Wallberg-Jonsson","year":"1995","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1136\/ard.56.6.341_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0049-0172(05)80030-7","article-title":"Antilipoprotein antibodies in rheumatoid arthritis.","volume":"22","author":"Lazarevic","year":"1993","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1136\/ard.56.6.341_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0021-9681(76)90086-2","article-title":"Mortality among arthritics.","volume":"29","author":"Monson","year":"1976","journal-title":"J Chron Dis"},{"key":"10.1136\/ard.56.6.341_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0021-9150(87)90117-1","article-title":"The effects of short term low dose corticosteroids on plasma lipoprotein lipids.","volume":"63","author":"Ettinger","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1136\/ard.56.6.341_bib19","first-page":"445","article-title":"Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.","volume":"24","author":"Wallberg-Jonsson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.56.6.341_bib20","first-page":"415","article-title":"Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids?","volume":"24","author":"Raynauld","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.56.6.341_bib21","first-page":"3670","article-title":"Lipid abnormalities in renal transplant recipients treated with cyclosporine.","volume":"21","author":"Vathsala","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1136\/ard.56.6.341_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9343(90)90345-E","article-title":"Cholesterol lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids.","volume":"89","author":"Wallace","year":"1990","journal-title":"Am J Med"},{"key":"10.1136\/ard.56.6.341_bib23","first-page":"340","article-title":"Can chloroquine be of value in the treatment of hypercholesterolaemia?","volume":"13","author":"Benyen","year":"1986","journal-title":"Artery"},{"key":"10.1136\/ard.56.6.341_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based prospective studies.","volume":"3","author":"Hokanson","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"10.1136\/ard.56.6.341_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/bmj.303.6808.953","article-title":"Dietary reduction of serum cholesterol: time to think again.","volume":"303","author":"Ramsay","year":"1991","journal-title":"BMJ"},{"key":"10.1136\/ard.56.6.341_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/bmj.308.6925.367","article-title":"By how much and how quickly does reduction in serum cholesterol concentration lower risk of IHD?","volume":"308","author":"Law","year":"1994","journal-title":"BMJ"},{"key":"10.1136\/ard.56.6.341_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/dtb.1996.341289","article-title":"Management of hyperlipidaemia.","volume":"34","year":"1996","journal-title":"Drug Ther Bull"},{"key":"10.1136\/ard.56.6.341_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"The West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia.","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.56.6.341_bib29","doi-asserted-by":"crossref","first-page":"s50","DOI":"10.1177\/0961203396005001121","article-title":"The use of antimalarials in combination with other disease modifying agents in RA - the British experience.","volume":"5 (suppl 1)","author":"Duncan","year":"1996","journal-title":"Lupus"},{"key":"10.1136\/ard.56.6.341_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1471-0528.1992.tb14414.x","article-title":"The risk of acute myocardial infarction after oestrogen and oestrogen progesterone replacement.","volume":"99","author":"Falkeborn","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1136\/ard.56.6.341_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/ard.55.11.837","article-title":"Glutathione reductase activity, riboflavin status and disease activity in rheumatoid arthritis.","volume":"55","author":"Mulherin","year":"1996","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724402409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724402409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.56.6.341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:29:55Z","timestamp":1737545395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724402409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["S0003496724402409"],"URL":"https:\/\/doi.org\/10.1136\/ard.56.6.341","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1997,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyslipidaemia and rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.56.6.341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}